NEW YORK, Sept. 17 /PRNewswire/ -- ExL Pharma is pleased to announce three Clinical Data Focused conferences which cover many of the leading issues that are impacting the pharmaceutical industry today. These events offer educational and networking opportunities for Clinical, R&D, Regulatory and Medical Affairs executives from large to small pharmaceutical, biotech, device and medical technology companies.
Listed below are details on some of the featured events and highlights from those conferences:
October 15-16, San Francisco, CA
2nd Data Monitoring Committees/DSMBs Conference -- Evaluating Trial Safety
and Efficacy through Independent Examination of Interim Clinical Data
Following a successful inaugural DMC conference in February of 2007, where over 100 industry experts gathered in Philly, ExL Pharma is proud to announce the 2nd DMC conference taking place October 15-16 in San Francisco where the industry will once again gather to evaluate trial safety and efficacy through independent examination of interim clinical data. Hear case study examples from GSK, AstraZeneca, Genentech, Amgen and join the industry's leading authorities on Drug Safety, Regulatory Affairs and Biostatistics to discuss experiences, strategies and best practices for working with DMCs and incorporating them into clinical trial designs to mitigate risk, optimize resource allocation, reassure study integrity and increase safety.
November 5-6, Arlington, VA
Pediatric Clinical Trials Conference -- Increasing Efficiency in Drug
Development by Redefining Global Regulation and Identifying Trial
Featuring roundtable discussions chaired by Dean Steven Spielberg from
Dartmouth Medical School; topics lead by experts in each field include
CNS/Psychiatry, Infectious Disease, Oncology, Gastroenterology, and
Geographic Study Differences. Other event presentations include NICHD
perspective on Best Pharmaceuticals for Children Act,
|SOURCE ExL Pharma|
Copyright©2007 PR Newswire.
All rights reserved